Published in Nucleic Acids Res on September 21, 2005
Global signatures of protein and mRNA expression levels. Mol Biosyst (2009) 4.43
MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest (2012) 2.24
Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res (2013) 2.01
Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One (2010) 1.73
Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways. PLoS One (2014) 1.49
Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood (2009) 1.46
ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs. Genome Res (2014) 1.37
Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC Bioinformatics (2013) 1.28
Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am (2008) 1.10
Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. J Immunol (2008) 1.09
Eicosapentaenoic acid protects against palmitic acid-induced endothelial dysfunction via activation of the AMPK/eNOS pathway. Int J Mol Sci (2014) 0.99
Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes (2011) 0.99
Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization. Invest Ophthalmol Vis Sci (2006) 0.95
Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol (2009) 0.93
NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases. Proc Natl Acad Sci U S A (2013) 0.90
Differential regulation of endothelial cell activation by complement and interleukin 1alpha. Circ Res (2006) 0.89
NFĸB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiol Biochem (2011) 0.89
Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol. PLoS Genet (2011) 0.88
Allelic expression mapping across cellular lineages to establish impact of non-coding SNPs. Mol Syst Biol (2014) 0.86
Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB. Nucleic Acids Res (2013) 0.85
A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int J Nanomedicine (2012) 0.85
The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects Endothelial Gene Expression. PLoS One (2015) 0.84
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG / NEMO mutations. Blood (2017) 0.83
NF-kappaB activity in endothelial cells is modulated by cell substratum interactions and influences chemokine-mediated adhesion of natural killer cells. Cell Transplant (2009) 0.82
P120 catenin attenuates lipopolysaccharide-induced blood-brain barrier dysfunction and inflammatory responses in human brain microvascular endothelial cells. Int J Clin Exp Pathol (2015) 0.80
Bestrophin 3 ameliorates TNFα-induced inflammation by inhibiting NF-κB activation in endothelial cells. PLoS One (2014) 0.80
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III. Evid Based Complement Alternat Med (2011) 0.80
Bench-to-bedside review: ventilatory abnormalities in sepsis. Crit Care (2009) 0.79
Caveolae control the anti-inflammatory phenotype of senescent endothelial cells. Aging Cell (2014) 0.79
Constitutive repression of interleukin-1alpha in endothelial cells. Circ Res (2008) 0.79
Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis. Mediators Inflamm (2016) 0.79
Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice. Lipids Health Dis (2016) 0.78
Shikonin Isolated from Lithospermum erythrorhizon Downregulates Proinflammatory Mediators in Lipopolysaccharide-Stimulated BV2 Microglial Cells by Suppressing Crosstalk between Reactive Oxygen Species and NF-κB. Biomol Ther (Seoul) (2015) 0.78
Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin. PLoS Negl Trop Dis (2015) 0.78
MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4. Int J Mol Med (2016) 0.78
The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis. Int J Mol Sci (2013) 0.78
Transcription factor MEF2C suppresses endothelial cell inflammation via regulation of NF-κB and KLF2. J Cell Physiol (2015) 0.78
Effects of 17 β-estradiol on lipopolysacharride-induced intracellular adhesion molecule-1 mRNA expression and Ca²+ homeostasis alteration in human endothelial cells. Vascul Pharmacol (2010) 0.77
A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis. PLoS One (2016) 0.76
Functional Gene Analysis Reveals Cell Cycle Changes and Inflammation in Endothelial Cells Irradiated with a Single X-ray Dose. Front Pharmacol (2017) 0.76
Ulmus davidiana ethanol extract inhibits monocyte adhesion to tumor necrosis factor-alpha-stimulated endothelial cells. Integr Med Res (2016) 0.75
Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model. Atherosclerosis (2016) 0.75
NFκB activation in cutaneous lesions of leprosy is associated with development of multibacillary infection. J Inflamm Res (2014) 0.75
Modulation of IL-27 in adipocytes during inflammatory stress. Obesity (Silver Spring) (2015) 0.75
The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation. Br J Pharmacol (2016) 0.75
Candida albicans triggers the expression of inflammatory genes in human umbilical vein endothelial cells. Exp Ther Med (2016) 0.75
Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions. J Biol Chem (2016) 0.75
Influence of hypothermia and subsequent rewarming upon leukocyte-endothelial interactions and expression of Junctional-Adhesion-Molecules A and B. Sci Rep (2016) 0.75
[Structural and morphological changes in the eyes of arterial hypertensive patients with and without anti-CCP-positive rheumatoid arthritis]. Ophthalmologe (2017) 0.75
Chrysin Attenuates VCAM-1 Expression and Monocyte Adhesion in Lipopolysaccharide-Stimulated Brain Endothelial Cells by Preventing NF-κB Signaling. Int J Mol Sci (2017) 0.75
Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a. Circ Res (2017) 0.75
Role of free fatty acids in endothelial dysfunction. J Biomed Sci (2017) 0.75
Inflammation in atherosclerosis. Nature (2002) 28.92
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Missing pieces in the NF-kappaB puzzle. Cell (2002) 17.83
Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46
Points of control in inflammation. Nature (2002) 10.61
IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity (2002) 8.19
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol (1992) 6.50
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell (2004) 6.13
The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell (2002) 5.84
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest (2004) 5.06
Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev (2000) 4.51
p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol (2001) 4.38
Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell (2004) 3.45
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17
A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet (1999) 2.56
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2003) 2.48
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol (1996) 2.34
Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (1993) 2.28
Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem (1999) 2.19
Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem (2001) 1.92
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation (2004) 1.91
Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci U S A (2002) 1.73
Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest (2003) 1.72
Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. Proc Natl Acad Sci U S A (2004) 1.67
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood (2004) 1.56
Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem (2004) 1.54
Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science (2004) 1.46
The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol (2004) 1.39
NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev (2003) 1.33
Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res (2003) 1.30
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood (2004) 1.23
Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway. J Biol Chem (2003) 1.18
The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice. J Biol Chem (2001) 1.11
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest (2004) 5.06
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood (2008) 3.03
Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem (2003) 1.91
IKK mediates ischemia-induced neuronal death. Nat Med (2005) 1.83
NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett (2010) 1.67
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst (2006) 1.63
TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone (2009) 1.55
Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol (2010) 1.41
Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology (2012) 1.40
Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res (2010) 1.40
Epithelial-mesenchymal transition: NF-kappaB takes center stage. Cell Cycle (2004) 1.38
KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood (2010) 1.38
Deficiency of innate and acquired immunity caused by an IKBKB mutation. N Engl J Med (2013) 1.37
p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet (2009) 1.33
Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood (2002) 1.32
FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood (2012) 1.31
Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol (2002) 1.31
The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol (2003) 1.25
Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood (2005) 1.24
Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest (2007) 1.24
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood (2004) 1.23
Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J Biol Chem (2002) 1.21
Identification of novel Myc target genes with a potential role in lymphomagenesis. Nucleic Acids Res (2004) 1.20
Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure. Proc Natl Acad Sci U S A (2012) 1.17
Iodoxolone-based hypervalent iodine reagents. Org Lett (2009) 1.15
Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol (2010) 1.14
A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet (2002) 1.14
Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol (2004) 1.12
The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis. Blood (2009) 1.11
The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice. J Biol Chem (2001) 1.11
C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma. Int J Cancer (2007) 1.11
Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J Biotechnol (2007) 1.10
Advanced organic synthesis using microreactor technology. Org Biomol Chem (2006) 1.10
BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses. EMBO J (2007) 1.10
FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovasc Res (2011) 1.09
IκB kinase/nuclear factor κB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling. J Neurosci (2012) 1.08
Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses. Cancer Res (2009) 1.06
Reversible lymphomagenesis in conditionally c-MYC expressing mice. Int J Cancer (2004) 1.06
Iodine monochloride-amine complexes: an experimental and computational approach to new chiral electrophiles. Chemistry (2005) 1.06
Reagent-controlled stereoselective iodolactonizations. Org Lett (2002) 1.03
B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice. J Exp Med (2003) 1.02
BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol Cell Biol (2002) 1.01
Challenges in monoclonal antibody-based therapies. Ann Med (2009) 1.00
Hypervalent iodine goes catalytic. Angew Chem Int Ed Engl (2006) 1.00
Repressing the repressor: a new mode of MYC action in lymphomagenesis. Cell Cycle (2009) 1.00
Iodine electrophiles in stereoselective reactions: recent developments and synthetic applications. Chem Soc Rev (2004) 0.99
Adenovirus mediated herpes simplex virus-thymidine kinase/ganciclovir gene therapy for resectable malignant glioma. Curr Gene Ther (2009) 0.99
Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity. Eur J Pharm Biopharm (2008) 0.99
Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2. Gut (2006) 0.98
Highly stereoselective metal-free oxyaminations using chiral hypervalent iodine reagents. Angew Chem Int Ed Engl (2012) 0.94
Improving safety of gene therapy. Curr Drug Saf (2008) 0.94
Epithelial-mesenchymal transition in pancreatic carcinoma. Cancers (Basel) (2010) 0.94
Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol (2009) 0.93
Controlling hazardous chemicals in microreactors: synthesis with iodine azide. Beilstein J Org Chem (2009) 0.92
Determination of hip reduction in spica cast treatment for DDH: a comparison of radiography and ultrasound. J Child Orthop (2009) 0.92
Selenium-containing naphthalimides as anticancer agents: design, synthesis and bioactivity. Bioorg Med Chem (2012) 0.92
Long-term IKK2/NF-κB signaling in pancreatic β-cells induces immune-mediated diabetes. Diabetes (2013) 0.90
Stereoselective rearrangements with chiral hypervalent iodine reagents. Angew Chem Int Ed Engl (2013) 0.88
Myc regulates embryonic vascular permeability and remodeling. Circ Res (2009) 0.88
Activation of the IkappaB kinase complex is sufficient for neuronal differentiation of PC12 cells. J Neurochem (2005) 0.88
In vivo implantation of 2,2'-bis(oxazoline)-linked poly-epsilon-caprolactone: proof for enzyme sensitive surface erosion and biocompatibility. Eur J Pharm Sci (2008) 0.88
Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with aging. Mol Neurodegener (2013) 0.88
Nonunion of forearm shaft fractures in children after intramedullary nailing. J Pediatr Orthop B (2009) 0.87
CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Eur J Immunol (2002) 0.87
Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. J Biol Chem (2003) 0.87
Tetrafluoro-IBA and-IBX: hypervalent iodine reagents. Angew Chem Int Ed Engl (2007) 0.86
A practical microreactor for electrochemistry in flow. Beilstein J Org Chem (2011) 0.86
Nuclear factor κB activation impairs ependymal ciliogenesis and links neuroinflammation to hydrocephalus formation. J Neurosci (2012) 0.86
Flexible stereoselective functionalizations of ketones through umpolung with hypervalent iodine reagents. Angew Chem Int Ed Engl (2014) 0.86
Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models. Int J Cancer (2007) 0.86
Diazo compounds in continuous-flow technology. ChemSusChem (2014) 0.85
B cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice. J Immunol (2005) 0.85
Hypervalent iodine-mediated aziridination of alkenes: mechanistic insights and requirements for catalysis. Chemistry (2007) 0.85
Decitabine represses translocated MYC oncogene in Burkitt lymphoma. J Pathol (2013) 0.85
Hypervalent iodine-catalyzed oxidative functionalizations including stereoselective reactions. Chem Asian J (2014) 0.85
Selenocyclizations: control by coordination and by the counterion. Angew Chem Int Ed Engl (2004) 0.85
A multipurpose vector system for the screening of libraries in bacteria, insect and mammalian cells and expression in vivo. Nucleic Acids Res (2005) 0.85
Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinoma. PLoS One (2012) 0.85
Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB. Nucleic Acids Res (2013) 0.85
Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. Biochem Pharmacol (2002) 0.85
Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes. J Biol Chem (2003) 0.84
Critical role of RelB serine 368 for dimerization and p100 stabilization. J Biol Chem (2003) 0.84
Novel lactonization with phenonium ion participation induced by hypervalent iodine reagents. Org Lett (2003) 0.84
Doxycycline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells. Nucleic Acids Res (2004) 0.84
15-Lipoxygenase-1 induces lipid peroxidation and apoptosis, and improves survival in rat malignant glioma. In Vivo (2012) 0.83
Btk expression is controlled by Oct and BOB.1/OBF.1. Nucleic Acids Res (2006) 0.83
A versatile and highly reactive polyfluorinated hypervalent iodine(III) compound. Angew Chem Int Ed Engl (2010) 0.82
Intelligent microflow: development of self-optimizing reaction systems. Angew Chem Int Ed Engl (2011) 0.82
Selenium-catalyzed regioselective cyclization of unsaturated carboxylic acids using hypervalent iodine oxidants. Org Lett (2011) 0.81
Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol (2004) 0.81
Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways. Cancer Gene Ther (2004) 0.81
Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors. FASEB J (2012) 0.81
BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression. Genes Cancer (2010) 0.80
Catalytic use of selenium electrophiles in cyclizations. Org Lett (2007) 0.80
Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP. Neurobiol Dis (2012) 0.80
Avidin fusion protein-expressing lentiviral vector for targeted drug delivery. Hum Gene Ther (2009) 0.80
MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts. Carcinogenesis (2013) 0.80
Ritter reactions in flow. ChemSusChem (2011) 0.79
Initiation of dopaminergic differentiation of Nurr1(-) mesencephalic precursor cells depends on activation of multiple mitogen-activated protein kinase pathways. Stem Cells (2009) 0.79